GlaxoSmithKline Consumer Healthcare Pakistan Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was PKR 7,087.1 million compared to PKR 6,688.01 million a year ago. Net loss was PKR 279.31 million compared to net income of PKR 663.72 million a year ago. Basic loss per share from continuing operations was PKR 2.39 compared to basic earnings per share from continuing operations of PKR 5.67 a year ago.
For the six months, sales was PKR 14,214.25 million compared to PKR 11,922.84 million a year ago. Net income was PKR 277.29 million compared to PKR 1,278.73 million a year ago. Basic earnings per share from continuing operations was PKR 2.37 compared to PKR 10.92 a year ago.